Business Context and Reporting Period
This Form 8-K filing by DSS, INC. reports a material definitive agreement entered into on March 26, 2026. The company is incorporated in New York and its common stock trades on the NYSE American under the ticker symbol DSS.
Key Financial Metrics and Transaction Details
The filing details a financing transaction rather than standard periodic financial results. Key metrics include:
- Loan Amount: $2,450,000 principal.
- Interest Rate: 3% per annum (simple interest).
- Maturity Date: Five years from issuance.
- Conversion Price: $0.74 per share for the convertible note.
- Warrant Details: Option to purchase 16,554,055 shares at an exercise price of $0.93, expiring in five years.
The filing text does not provide current revenue, profit, cash flow, or existing debt levels outside of this new transaction.
Material Changes and Related Party Status
This transaction represents a significant change in the company's capital structure and is classified as a Related Party Transaction. The lender, Alset International Limited, is a majority-owned subsidiary of Alset Inc. Both DSS, Inc. and Alset Inc. are under the common control of Chan Heng Fai, who serves as Chairman of both entities. Additional directors and officers overlap between the two companies.
The transaction was approved by the DSS, Inc. Board of Directors and Audit Committee, with interested directors recusing themselves from voting.
Conditions, Risks, and Outlook
Closing Conditions: The transaction is subject to certain closing conditions, most notably the approval of the Company's stockholders.
Risks and Contingencies: The primary risk is the potential dilution of existing shareholders if the note is converted or warrants are exercised. The filing does not provide specific management commentary on future operational outlook or other risks beyond the terms of this agreement.
Investor Verification Checklist
- Verify the status of the required stockholder approval for the transaction to close.
- Review the full text of the Transaction Documents (Exhibits 10.1, 10.2, and 10.3) for covenants or default provisions not summarized here.
- Assess the potential dilution impact of 16,554,055 warrant shares plus potential note conversion on current share count.
- Confirm the current market price of DSS stock relative to the $0.74 conversion price and $0.93 warrant exercise price.